- Home
- LCFY vs NDRA Comparison
LCFY vs NDRA Comparison
Compare LCFY & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LCFY | NDRA |
|---|---|---|
| Founded | 2009 | 2007 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.3M | 8.1M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | LCFY | NDRA |
|---|---|---|
| Price | $2.35 | $5.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $30.00 |
| AVG Volume (30 Days) | 4.0K | ★ 54.4K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.32 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.10 | $2.96 |
| 52 Week High | $7.75 | $9.83 |
Technical Indicators
Market Signals| Indicator | LCFY | NDRA |
|---|---|---|
| Relative Strength Index (RSI) | 44.91 | 49.23 |
| Support Level | $2.28 | $4.43 |
| Resistance Level | $2.65 | $6.35 |
| Average True Range (ATR) | 0.13 | 0.63 |
| MACD | -0.00 | -0.06 |
| Stochastic Oscillator | 40.01 | 23.71 |
Price Performance
Historical ComparisonAbout LCFY Locafy Limited
Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.